Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 7
1982 2
1983 7
1984 7
1985 6
1986 8
1987 19
1988 7
1989 16
1990 12
1991 21
1992 17
1993 11
1994 15
1995 20
1996 7
1997 13
1998 12
1999 10
2000 18
2001 12
2002 17
2003 16
2004 11
2005 14
2006 14
2007 9
2008 7
2009 11
2010 7
2011 8
2012 9
2013 9
2014 3
2015 9
2016 3
2017 5
2018 2
2019 2
2020 1
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

394 results
Results by year
Filters applied: . Clear all
Page 1
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, McNulty SE, Velazquez EJ, Shah MR, Braunwald E; NHLBI Heart Failure Clinical Research Network. Redfield MM, et al. N Engl J Med. 2015 Dec 10;373(24):2314-24. doi: 10.1056/NEJMoa1510774. Epub 2015 Nov 8. N Engl J Med. 2015. PMID: 26549714 Free PMC article. Clinical Trial.
BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients. ...During all dose regimens, …
BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. …
Intravaginal administration of isosorbide mononitrate for cervical ripening in prolonged pregnancy: a randomised clinical trial.
Mirteimouri M, Pourali L, Najaf Najafi M, Ghaffarian Omid M. Mirteimouri M, et al. J Obstet Gynaecol. 2020 Aug;40(6):792-796. doi: 10.1080/01443615.2019.1669546. Epub 2019 Dec 18. J Obstet Gynaecol. 2020. PMID: 31852287 Clinical Trial.
This study was performed to evaluate the efficacy of intravaginal isosorbide mononitrate (IMN) for cervical ripening in prolonged pregnancies. 122 pregnant women were recruited. ...According to results of the current study; using isosorbide mononitrate
This study was performed to evaluate the efficacy of intravaginal isosorbide mononitrate (IMN) for cervical ripening in prolon …
Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH, O'Hara H, O'Hara J, Valle-Jones JC. Brodie NH, et al. Pharmatherapeutica. 1985;4(6):367-75. Pharmatherapeutica. 1985. PMID: 3936056 Clinical Trial.
Sub-lingual glyceryl trinitrate consumption was lower with isosorbide mononitrate than with sustained-release glyceryl trinitrate in 36 (75%) patients, but lower with sustained-release glyceryl trinitrate than with isosorbide mononitrate in only 5
Sub-lingual glyceryl trinitrate consumption was lower with isosorbide mononitrate than with sustained-release glyceryl trinitr …
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Patel RB, Vaduganathan M, Felker GM, Butler J, Redfield MM, Shah SJ. Patel RB, et al. Am J Cardiol. 2019 May 15;123(10):1660-1666. doi: 10.1016/j.amjcard.2019.02.025. Epub 2019 Feb 23. Am J Cardiol. 2019. PMID: 30876658 Free PMC article. Clinical Trial.
AF/AFL status was associated with higher baseline NT-proBNP (586 [25th to 75th percentile: 291 to 1254] pg/ml vs 154 [25th to 75th percentile: 92 to 288] pg/ml, p <0.001) and Kansas City Cardiomyopathy Questionnaire scores (69 [25th to 75th percentile: 46 to 88] vs 48 [25th to …
AF/AFL status was associated with higher baseline NT-proBNP (586 [25th to 75th percentile: 291 to 1254] pg/ml vs 154 [25th to 75th percentil …
Oral misoprostol and vaginal isosorbide mononitrate for labor induction: a randomized controlled trial.
Collingham JP, Fuh KC, Caughey AB, Pullen KM, Lyell DJ, El-Sayed YY. Collingham JP, et al. Obstet Gynecol. 2010 Jul;116(1):121-126. doi: 10.1097/AOG.0b013e3181e408f2. Obstet Gynecol. 2010. PMID: 20567177 Clinical Trial.
OBJECTIVE: To estimate whether vaginal isosorbide mononitrate, added to oral misoprostol for cervical ripening and labor induction, shortens time to vaginal delivery. ...Seventy-eight women received misoprostol, and 78 received misoprostol with isosorbide
OBJECTIVE: To estimate whether vaginal isosorbide mononitrate, added to oral misoprostol for cervical ripening and labor induc …
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination.
Blair GW, Appleton JP, Law ZK, Doubal F, Flaherty K, Dooley R, Shuler K, Richardson C, Hamilton I, Shi Y, Stringer M, Boyd J, Thrippleton MJ, Sprigg N, Bath PM, Wardlaw JM. Blair GW, et al. Int J Stroke. 2018 Jul;13(5):530-538. doi: 10.1177/1747493017731947. Epub 2017 Sep 14. Int J Stroke. 2018. PMID: 28906205 Clinical Trial.
Aim LACI-1 will assess the tolerability, safety, and efficacy, by dose, of isosorbide mononitrate and cilostazol, alone and in combination, in patients with ischemic lacunar stroke. ...Discussion This study will inform the design of a larger phase III trial of is
Aim LACI-1 will assess the tolerability, safety, and efficacy, by dose, of isosorbide mononitrate and cilostazol, alone and in …
Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R, Johnen R, Vydra L, Solbach C. Neuhaus R, et al. Pharmatherapeutica. 1986;4(8):486-95. Pharmatherapeutica. 1986. PMID: 3086899 Clinical Trial.
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart disease to compare the clinical efficacy of isosorbide 5-mononitrate 40 mg twice daily and the same regimen of sustained- …
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart di …
Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.
Tarhan F, Çelik O, Tosun Ç, Faydacı G, Eryıldırım B. Tarhan F, et al. Urol Int. 2014;93(1):17-21. doi: 10.1159/000357034. Epub 2014 Mar 13. Urol Int. 2014. PMID: 24643055 Clinical Trial.
OBJECTIVE: We aimed to compare the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms (LUTS). ...Isosorbide only improved IPSS (from 16.5 0.9 to 14.6 0.8) (p = 0.032). ...
OBJECTIVE: We aimed to compare the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract sy …
Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.
Abdellah MS, Hussien M, Aboalhassan A. Abdellah MS, et al. Arch Gynecol Obstet. 2011 Jul;284(1):25-30. doi: 10.1007/s00404-010-1572-4. Epub 2010 Jun 26. Arch Gynecol Obstet. 2011. PMID: 20582425 Clinical Trial.
OBJECTIVE: To evaluate the efficacy and safety of intravaginal administration of NOD isosorbide mononitrate (IMN) plus misoprostol versus misoprostol alone for cervical ripening and induction of labor. ...
OBJECTIVE: To evaluate the efficacy and safety of intravaginal administration of NOD isosorbide mononitrate (IMN) plus misopro …
Comparison of isosorbide mononitrate and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks: a randomized controlled trial.
Duhan N, Gupta S, Dahiya K, Sirohiwal D, Rohilla S. Duhan N, et al. Arch Gynecol Obstet. 2011 Jun;283(6):1245-8. doi: 10.1007/s00404-010-1535-9. Epub 2010 Jun 13. Arch Gynecol Obstet. 2011. PMID: 20549511 Clinical Trial.
AIM: The present study was undertaken to compare the efficacy of isosorbide mononitrate (IMN) and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks. ...The mean dilator sizes at which resistance was first encountered was 6.9 1.37 i …
AIM: The present study was undertaken to compare the efficacy of isosorbide mononitrate (IMN) and misoprostol for cervical rip …
394 results